Update in chronic obstructive pulmonary disease 2006.
Rabe
Klaus F
KF
Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
Beghé
Bianca
B
Luppi
Fabrizio
F
Fabbri
Leonardo M
LM
D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D000730:Androstadienes / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003952:Diagnostic Imaging; D000068298:Fluticasone; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D018482:Muscle, Skeletal / Q000503:physiopathology; D010102:Oxygen Inhalation Therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000175:diagnosis / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D012132:Respiratory Muscles / Q000503:physiopathology; D000068299:Salmeterol Xinafoate; D016540:Smoking Cessation
D000730:Androstadienes; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol